TI
PDSB icon

Trexquant Investment’s PDS Biotechnology PDSB Stock Holding History

Trexquant Investment’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-25,851
Closed -$131K – 1701
2023
Q3 		$131K Buy
+25,851
New +$142K ﹤0.01% 1383
2023
Q2 		– Sell
-38,110
Closed -$234K – 1713
2023
Q1 		$234K Buy
38,110
+14,002
+58% +$115K 0.01% 1279
2022
Q4 		$318K Buy
+24,108
New +$170K 0.01% 1083
2022
Q3 		– Sell
-15,151
Closed -$55K – 1736
2022
Q2 		$55K Sell
15,151
-69,436
-82% -$330K ﹤0.01% 1463
2022
Q1 		$524K Buy
84,587
+41,221
+95% +$256K 0.02% 748
2021
Q4 		$351K Buy
43,366
+980
+2% +$10.5K 0.02% 837
2021
Q3 		$632K Buy
+42,386
New +$528K 0.05% 443
2018
Q1 		– Sell
-705
Closed -$132K – 1301
2017
Q4 		$132K Buy
705
+100
+17% +$20.1K 0.01% 991
2017
Q3 		$130K Buy
+605
New +$125K 0.03% 704
2017
Q2 		– Sell
-783
Closed -$143K – 1086
2017
Q1 		$143K Buy
+783
New +$155K 0.02% 1009

Other funds holding PDSB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Trexquant Investment's PDSB Position: Q4 2023 in Review

Trexquant Investment sold out of PDS Biotechnology (PDSB) in Q4 2023, closing a stake of 25,851 shares — an estimated $131K sold.

Trexquant Investment first reported a position in PDSB in Q1 2017 and held it in 10 quarters. The position peaked at $632K in Q3 2021. 77 funds tracked by Wall St. Rank hold PDSB as of Q4 2023.

  • Trexquant Investment reported no remaining PDS Biotechnology position as of Q4 2023 after selling out during the quarter.
  • Trexquant Investment sold 25,851 PDS Biotechnology shares in Q4 2023, an estimated $131K.
  • Trexquant Investment first reported a position in PDS Biotechnology in Q1 2017 and held it in 10 quarters.
  • Trexquant Investment's PDS Biotechnology position peaked at $632K in Q3 2021.
  • 77 funds tracked by Wall St. Rank held PDS Biotechnology as of Q4 2023.

Based on Trexquant Investment's 13F filing for Q4 2023, filed 9 Feb 2024.